Arxis Inc (ARXS) Stock Forecast & Price Target

Arxis is favored because it has repeatedly outperformed since its 2026 IPO, with 1Q26 revenue of $459M (+21% YoY, +17% organic), 2Q26 organic growth of 21%, and 2Q26 net debt of only $1.2B, or 1.8x net leverage, leaving room for more accretive deals. Its outlook is further supported by five post-IPO acquisitions, including Omnetics, which should add about $59M of revenue in 2026 and roughly $114M in 2027, while reinforcing management’s ability to acquire durable, high-margin businesses and double EBITDA over 3-5 years. The stock also benefits from proprietary, mission-critical components, strong pricing power in defense and industrial end markets, and an estimated 2028 EBITDA of $1,131M that supports continued margin expansion and upside from both organic execution and M&A.

Arxis is exposed to slower top-line growth if defense sales soften or OEM ramp headwinds persist, with downside cases implying revenue CAGR of just 12%, 9%, or 7.5% through 2028 and sales of only $2.25B, $2.1B, or $2.0B. At those levels, adjusted EBITDA would compress to about $880M, $814M, or $770M even with margins near 39% to 38%, highlighting limited earnings leverage if growth disappoints. Its defense-contractor exposure also creates sustainability and political risk, while aircraft delivery timing, defense appropriations, M&A execution, proprietary new-business wins, and macro/geopolitical volatility add meaningful downside uncertainty.